Enzybro 90mg Tablet is a combination pharmaceutical formulation containing Bromelain 90mg, Trypsin 48mg, and Rutoside 100mg, designed to provide anti-inflammatory, proteolytic, and vascular protective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins and exhibits significant anti-inflammatory and analgesic properties, making it effective in reducing edema and promoting tissue repair. Trypsin, a serine protease enzyme, enhances the proteolytic activity, aiding in the degradation of inflammatory mediators and fibrin deposits, thereby supporting faster resolution of inflammation and improving wound healing. Rutoside, a bioflavonoid, acts as a potent antioxidant and vascular protector by strengthening capillary walls, reducing capillary permeability, and preventing microvascular bleeding. The synergistic action of these components makes Enzybro 90mg Tablet suitable for managing conditions associated with inflammation, edema, and microcirculatory disturbances, such as post-traumatic swelling, postoperative inflammation, and chronic venous insufficiency. It is indicated as an adjunct therapy in musculoskeletal injuries, surgical recovery, and inflammatory disorders. Enzybro should be used under medical supervision, with caution advised in patients with hypersensitivity to any of the components or underlying bleeding disorders. The dosage and duration of therapy should be tailored according to clinical response and physician guidance.